Cargando…

Enhancing the public health impact of latent tuberculosis infection diagnosis and treatment (ACT4): protocol for a cluster randomised trial

INTRODUCTION: Treatment of latent tuberculosis (TB) infection (LTBI) is an important component of the End-TB strategy. However, the number of individuals who successfully complete LTBI treatment remains low as there are losses at all steps in the LTBI ‘cascade-of-care’. The reasons for these losses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oxlade, Olivia, Trajman, Anete, Benedetti, Andrea, Adjobimey, Mênonli, Cook, Victoria J, Fisher, Dina, Fox, Gregory James, Fregonese, Federica, Hadisoemarto, Panji, Hill, Philip C, Johnston, James, Long, Richard, Obeng, Joseph, Ruslami, Rovina, Valiquette, Chantal, Menzies, Dick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Global Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527985/ https://www.ncbi.nlm.nih.gov/pubmed/30898826 http://dx.doi.org/10.1136/bmjopen-2018-025831

Ejemplares similares

GeneXpert or chest-X-ray or tuberculin skin testing for household contact assessment (GXT): protocol for a cluster-randomized trial
por: Trajman, Anete, et al.
Publicado: (2022)

Effects of programmatic interventions to improve the management of latent tuberculosis: a follow up study up to five months after implementation
por: Yanes-Lane, Mercedes, et al.
Publicado: (2021)

Solutions to improve the latent tuberculosis Cascade of Care in Ghana: a longitudinal impact assessment
por: Barss, Leila, et al.
Publicado: (2020)

Resource implications of the latent tuberculosis cascade of care: a time and motion study in five countries
por: Alsdurf, H., et al.
Publicado: (2020)

How Methodologic Differences Affect Results of Economic Analyses: A Systematic Review of Interferon Gamma Release Assays for the Diagnosis of LTBI
por: Oxlade, Olivia, et al.
Publicado: (2013)

High dose rifampin for 2 months vs standard dose rifampin for 4 months, to treat TB infection: Protocol of a 3-arm randomized trial (2R(2))
por: Fregonese, Federica, et al.
Publicado: (2023)

Individualized Treatment Duration in Tuberculosis Treatment: Precision versus Simplicity
por: Adjobimey, Menonli, et al.
Publicado: (2021)

Scaling up investigation and treatment of household contacts of tuberculosis patients in Brazil: a cost-effectiveness and budget impact analysis
por: Bastos, Mayara Lisboa, et al.
Publicado: (2022)

The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: A modelling study
por: Romanowski, Kamila, et al.
Publicado: (2019)

Patients' Costs and Cost-Effectiveness of Tuberculosis Treatment in DOTS and Non-DOTS Facilities in Rio de Janeiro, Brazil
por: Steffen, Ricardo, et al.
Publicado: (2010)

Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
por: Oehadian, Amaylia, et al.
Publicado: (2022)

Anemia with elevation of growth differentiation factor-15 level in linezolid treated multidrug-resistant tuberculosis: Case series of three patients
por: Oehadian, Amaylia, et al.
Publicado: (2022)

The mTST – An mHealth approach for training and quality assurance of tuberculin skin test administration and reading
por: Moayedi-Nia, Saeedeh, et al.
Publicado: (2019)

The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis
por: Bastos, Mayara Lisboa, et al.
Publicado: (2021)

Cost-Effectiveness of Quantiferon®-TB Gold-In-Tube Versus Tuberculin Skin Testing for Contact Screening and Treatment of Latent Tuberculosis Infection in Brazil
por: Steffen, Ricardo Ewbank, et al.
Publicado: (2013)

Correction: The impact of the Brazilian family health on selected primary care sensitive conditions: A systematic review
por: Bastos, Mayara Lisboa, et al.
Publicado: (2017)

The impact of the Brazilian family health on selected primary care sensitive conditions: A systematic review
por: Bastos, Mayara Lisboa, et al.
Publicado: (2017)

Evaluating the potential costs and impact of digital health technologies for tuberculosis treatment support
por: Nsengiyumva, Ntwali Placide, et al.
Publicado: (2018)

Modeling the impact of tuberculosis interventions on epidemiologic outcomes and health system costs
por: Oxlade, Olivia, et al.
Publicado: (2015)

Tuberculosis preventive treatment in people living with HIV—Is the glass half empty or half full?
por: Oxlade, Olivia, et al.
Publicado: (2021)

Public Acceptance and Willingness-to-Pay for a Future Dengue Vaccine: A Community-Based Survey in Bandung, Indonesia
por: Hadisoemarto, Panji Fortuna, et al.
Publicado: (2013)

Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence
por: Trajman, A., et al.
Publicado: (2013)

Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis
por: Yanes-Lane, Mercedes, et al.
Publicado: (2021)

Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study
por: Tseng, Chia-Lin, et al.
Publicado: (2011)

Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis
por: Uppal, Aashna, et al.
Publicado: (2021)

Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis
por: Lisboa Bastos, Mayara, et al.
Publicado: (2020)

Added Value of QuantiFERON TB-Gold in-Tube for Detecting Latent Tuberculosis Infection among Persons Living with HIV/AIDS
por: Souza, Josiane Maria Oliveira, et al.
Publicado: (2014)

Knowledge about tuberculosis transmission and prevention and perceptions of health service utilization among index cases and contacts in Brazil: Understanding losses in the latent tuberculosis cascade of care
por: Salame, Flavia Matos, et al.
Publicado: (2017)

Introduction of pentavalent vaccine in Indonesia: a policy analysis
por: Hadisoemarto, Panji F, et al.
Publicado: (2016)

Mycobacterium tuberculosis infection and disease in healthcare workers in a tertiary referral hospital in Bandung, Indonesia
por: Apriani, Lika, et al.
Publicado: (2022)

Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness
por: Nsengiyumva, Ntwali Placide, et al.
Publicado: (2022)

Active and latent tuberculosis in refugees and asylum seekers: a systematic review and meta-analysis
por: Proença, Raquel, et al.
Publicado: (2020)

Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti
por: Jacquet, Vary, et al.
Publicado: (2006)

Identifying gaps in the quality of latent tuberculosis infection care
por: Hannah, Alsdurf, et al.
Publicado: (2020)

Tuberculosis Case Finding in Benin, 2000–2014 and Beyond: A Retrospective Cohort and Time Series Study
por: Ade, Serge, et al.
Publicado: (2016)

Four months of rifampicin monotherapy for latent tuberculosis infection in children
por: Oh, Chi Eun, et al.
Publicado: (2021)

Knowledge and perceptions of tuberculosis transmission and prevention among physicians and nurses in three Brazilian capitals with high incidence of tuberculosis
por: Ramos, Jonas, et al.
Publicado: (2018)

Recent developments in treatment of latent tuberculosis infection
por: Menzies, Dick, et al.
Publicado: (2011)

Efficacy and effectiveness of SARS-CoV-2 vaccines for death prevention: A protocol for a systematic review and meta-analysis
por: Trajman, Anete, et al.
Publicado: (2022)

Knowledge, attitudes and practices on tuberculosis transmission and prevention among auxiliary healthcare professionals in three Brazilian high-burden cities: a cross-sectional survey
por: Trajman, Anete, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_21t3gvgu9ah29ugmeejl2uislt